![Bianca M. Freda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ms. Freda joined the Foundation in April 2008 as a program associate on the Quality/Equality Team.
Her work focuses on supporting the team’s Regional Quality Strategy to help targeted communities across the United States improve and sustain high quality, patient-centered, equitable care by 2015.
Prior to joining RWJF, Ms. Freda worked for the New Jersey Department of Health and Senior Services as a research assistant in the Center for Health Statistics.
She also has served in a variety of health care marketing, medical education, and program management positions at Johnson & Johnson and Bristol-Myers Squibb.
Ms. Freda received a BA in molecular biology and genetics from Princeton University and is completing a Master of Public Health at the University of Medicine and Dentistry of New Jersey School of Public Health.
She is also a member of the New Jersey Society for Public Health Education.
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous RWJF seeks to earn an investment return that, over time, equals or exceeds the sum of its annual spending, as a percentage of the Foundation’s assets plus the rate of inflation. This balance of investment return and spending is designed to spread risk and promote a steady, stable flow of support for our grantees. Since the firm focuses their philanthropy on meeting many of the nation’s most critical health challenges, they seek to avoid investments in companies whose businesses are predominantly related to the manufacture, sale, or distribution of firearms, alcohol, cannabis, or tobacco-related products. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
The Robert Wood Johnson Foundation
The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous RWJF seeks to earn an investment return that, over time, equals or exceeds the sum of its annual spending, as a percentage of the Foundation’s assets plus the rate of inflation. This balance of investment return and spending is designed to spread risk and promote a steady, stable flow of support for our grantees. Since the firm focuses their philanthropy on meeting many of the nation’s most critical health challenges, they seek to avoid investments in companies whose businesses are predominantly related to the manufacture, sale, or distribution of firearms, alcohol, cannabis, or tobacco-related products. | Miscellaneous |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
